We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Peter Lin

Peter Lin MD, CCFP

Director, Primary Care Initiatives, Canadian Heart Research Centre, Ontario, Canada

Dr. Peter Lin began his studies in the Faculty of Science and Engineering at the University of Toronto in Toronto, Ontario. Midway through, he moved to the Faculty of Medicine, where he completed his studies and became involved in research. Over the years, it became apparent to him that there was a wide chasm between research and clinical practice, and he moved into clinical practice in primary care and eventually into teaching in order to help bridge this gap. He served as the medical director at the Health & Wellness Centre, University of Toronto Scarborough, for 7 years. Currently, he is the Director of Primary Care Initiatives at the Canadian Heart Research Centre. He lectures and speaks international on a variety of topics and maintains a busy family practice in Toronto.

Dr. Lin was a consultant for Perspectives in Cardiology, and was on the editorial board of The Canadian Review of Alzheimer's Disease and Other Dementias. He had been the chairman of the Dementia Congress in the US for 4 years. He has also served on the editorial board of Pri-Med. Dr. Lin received a teaching award from the College of Family Physicians in 2011.

Disclosures

Dr. Lin has consulted with the following companies on Continuing Medical Education programs:

Astrazeneca, Boeringher Ingelheim, Bayer, Eli Lilly, Amgen, Janssen, Merck, Novartis, Pfizer, Servier, Sanofi, Abbott, Mylan, HLS Therapeutics Inc.

He also does Continuing Medical Education for the companies.  No clinical trials. No patents.